Ignite Creation Date:
2024-05-06 @ 1:05 AM
Last Modification Date:
2024-10-26 @ 10:59 AM
Study NCT ID:
NCT01728818
Status:
UNKNOWN
Last Update Posted:
2017-07-19
First Post:
2012-07-05
Brief Title:
Afatinib as Cancer Therapy for Exocrine Pancreatic Tumours
Sponsor:
PD Dr med Volker Heinemann
Organization:
Ludwig-Maximilians - University of Munich
Organization Data
Organization:
Ludwig-Maximilians - University of Munich
Class:
OTHER
Study ID:
2011-004063-77
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
PD Dr med Volker Heinemann
Lead Sponsor Class:
OTHER
Responsible Party:
PD Dr med Volker Heinemann
Responsible Party Title:
Sponsor Delegated Person
Responsible Party Type:
SPONSOR_INVESTIGATOR
Responsible Party Affiliation:
Ludwig-Maximilians - University of Munich
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| Boehringer Ingelheim | INDUSTRY |